Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • Dec. 22, 2022, 12:39 UTC
  • 25
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • Dec. 22, 2022, 12:39 UTC
  • 25
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text

SQUARE PHARMS

  • FDA Approval
  • Dec. 22, 2022, 12:39 UTC
  • 26
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

ALLERGAN

  • FDA Approval
  • Dec. 21, 2022, 18:17 UTC
  • 29
  • 0 comments

FDA approve AVIBACTAM SODIUM; CEFTAZIDIME

Comment Full text

EXELTIS USA INC

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 24
  • 0 comments

FDA approve DROSPIRENONE

Comment Full text

AMNEAL

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 23
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

RADIUS HEALTH INC

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 27
  • 0 comments

FDA approve ABALOPARATIDE

Comment Full text

INCYTE CORP

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 25
  • 0 comments

FDA approve RUXOLITINIB PHOSPHATE

Comment Full text

LUPIN

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 24
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

ALLERGAN

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 27
  • 0 comments

FDA approve DEXAMETHASONE

Comment Full text
  • Previous
  • 914
  • 915
  • 916
  • 917
  • 918
  • Next

Search

News categories

  • Technical Exchange News(12261)
  • Event(6229)
  • SEC News(267570)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155692)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin